Rob Bigham Email & Phone Number

Grosse Pointe, MI, US

Durham, NC, US

• Responsible for favorable access for Orladeyo at PBM’s, National and Regional Accounts in the Midwest and Northeast (CVS/Caremark, Aetna, BCBS of Michigan, Priority Health, HAP, Medical Mutual, Highmark, UPMC.
• Implement PBM/MCO disease state and pull-through strategies for Orladeyo.
• Secure timely and optimal product access that supports commercial objectives
• Responsible for proactively working with sales teams and patient services to identify opportunities and/or resolving patient access issues
• Serve as a field expert on all Market Access and fulfillment needs for assigned accounts
• Partner with assigned Medical Science Liaison (MSL) to proactively communicate approved disease education messages for therapeutic areas of interest including responding to therapeutic class reviews, unsolicited.

Durham, NC, US

• Multiple National and Regional market access roles across the country due to company acquisitions. Responsible for profitable access in these rare disease/specialty markets. Hereditary Angioedema, Gaucher’s Disease.
• Hereditary Angioedema expertise (Launched Cinryze & Takhzyro)
• Specialty/Rare disease problem solver in Commercial & Government accounts
• Deep experience in distribution networks
• Strong relationships in larger Commercial and Government payers
• Member of the Rare Disease/Patient Services (MAPS) team resolving numerous Commercial and Government payers issues across the country

• Senior Corporate Account Director-Launched Ultra Orphan/Rare Disease Medication Cinryze in 20 Midwest/Central States and was responsible for access at all Regional and National accounts plus State Medicaids.
• Achieved excellent Payer coverage of 98%. *National Account Specialty Pharmacy relationships: Caremark, Accredo, Orsini*Primary National & Regional Accounts: United Healthcare, Anthem, Cigna, Aetna, Humana, BCBS – IL.
• Negotiated all contracts
• Was responsible for 60% of the Cinryze business ($360,000,000)
• Negotiated the exception dose policy with Caremark-Annual cost savings of over $300,000 for ViroPharma
• Consistently exceeded Caremark new patient approvals over the past 5 years by 135%

Cambridge, MA, US

Secured favorable payer coverage for Tysabri, Avonex & Amevive in a 7-state territory: Michigan, Ohio, Illinois, Minnesota, Wisconsin, Indiana and Kentucky. Key accounts are BCBS of Michigan, Illinois, Minnesota, Anthem Ohio, Medical Mutual, Medica, Health Partners, Blue Care Network, Priority Health, Caremark, Option Care and Prime Therapeutics.

Secured favorable payer coverage for OxyContin, MS Contin, Uniphyl, Palladone and Spectracef in Michigan, Ohio and Western New York. Key accounts were BCBS of Michigan, Blue Care Network, Priority Health, Health Alliance Plan, and Medical Mutual. Anthem Ohio, Excellus, Independent Health. Also a registered Lobbyist in the State of Michigan.

Bba, Marketing

Education record